Antisense oligonucleotide targeting the ATM gene: Clinical Trials

1 trial of Antisense oligonucleotide targeting the ATM gene, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Antisense oligonucleotide targeting the ATM gene: new trials by email Literature Review of Antisense oligonucleotide targeting the ATM gene trials Research Report on Antisense oligonucleotide targeting the ATM gene

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T)
Antisense oligonucleotide targeting the ATM gene - Ataxia Telangiectasia
Phase 1 / Phase 2RecruitingTimothy Yu102026-08-012026-05-28

Conditions studied

Ataxia Telangiectasia (1)

Sponsors

Timothy Yu (1)

Countries

United States (1)

Top investigators

Christelle Achkar, MD (1)  ·  Timothy Yu, MD, PhD (1)